BRIEF published on 03/25/2024 at 15:31, 7 months 26 days ago The Vanguard Group Reports Ownership in Direct Line Insurance Group plc The Vanguard Group Takeover Code Ownership Disclosure Direct Line Insurance Investment Transparency
PRESS RELEASE published on 03/25/2024 at 15:26, 7 months 26 days ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.00% interest in Direct Line Insurance Group plc. Purchase of 12,040 Ordinary 10 10/11p shares at 2.09 GBP per unit Form 8.3 The Vanguard Group Inc. Securities Disclosure Stock Purchase Direct Line Insurance Group Plc
BRIEF published on 03/22/2024 at 15:31, 7 months 29 days ago The Vanguard Group Announces 5% Stake in Direct Line Insurance Group PLC Investment The Vanguard Group Financial Disclosure Insurance Sector Direct Line Insurance
PRESS RELEASE published on 03/22/2024 at 15:26, 7 months 29 days ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group PLC The Vanguard Group, Inc. discloses a 5.00% ownership in Direct Line Insurance Group PLC as of 21 March 2024, with recent securities transactions Form 8.3 The Vanguard Group Inc. Ownership Disclosure Securities Transactions Direct Line Insurance Group Plc
BRIEF published on 03/20/2024 at 14:36, 8 months ago Vanguard Group Increases Stake in Direct Line Insurance Group plc Vanguard Group Financial Markets Insurance Sector Direct Line Insurance Stock Investment
PRESS RELEASE published on 03/20/2024 at 14:31, 8 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.00% ownership position in Direct Line Insurance Group plc as of 19 March 2024 Form 8.3 The Vanguard Group Inc. Securities Disclosure Ownership Position Direct Line Insurance Group Plc
BRIEF published on 03/19/2024 at 15:32, 8 months 1 day ago The Vanguard Group, Inc. Reports Stake in Direct Line Insurance Group plc The Vanguard Group Takeover Code Shareholding Direct Line Insurance Group Plc Financial Investments
PRESS RELEASE published on 03/19/2024 at 15:27, 8 months 1 day ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. makes a Form 8.3 disclosure regarding Direct Line Insurance Group plc. Details of ownership and positions disclosed Form 8.3 Disclosure The Vanguard Group Inc. Direct Line Insurance Group Plc Positions
BRIEF published on 03/18/2024 at 15:17, 8 months 2 days ago Vanguard Group Discloses Stake in Direct Line Insurance Group PLC Shares Disclosure Investment The Vanguard Group Direct Line Insurance Group Plc
PRESS RELEASE published on 03/18/2024 at 15:12, 8 months 2 days ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group PLC The Vanguard Group, Inc. discloses a 5.00% ownership in Direct Line Insurance Group PLC as of 15 March 2024. Additional dealings include purchases and sales of ordinary securities Form 8.3 Securities Dealings The Vanguard Group Inc. Ownership Disclosure Direct Line Insurance Group Plc
Published on 11/21/2024 at 13:00, 26 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 26 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 26 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 26 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 26 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 51 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 11 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 28 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 6 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 41 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 41 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo